Actos May Cause Bladder Cancer


Actos (piogliatazone), the Type 2 Diabetes drug that is used in conjunction with diet and exercise to improve the control of blood sugar in adults, has been linked to an increase risk in bladder cancer. In June 2011, regulators in France and Germany decided to no longer allow the sale of the highly successful drug after a study conducted by the French Medicines Agency found that there was 22 percent greater risk in developing bladder cancer in individuals consuming  Actos compared to individuals receiving other drugs.

Approved in July 1999, Actos sales were $2.9 billion in 2006 but increased significantly after issues arose with Avandia, the only other drug in the class. Avandia and Actos have been linked to adverse effects on the heart. In 2007, The U.S. Food and Drug Administration announced that they recommended Actos label information should contain a warning about the increased risk of heart failure in some patients.

After the FDA warned about the potential of developing bladder cancer from Actos in June 2011, complaints and lawsuits began to grow rapidly throughout the United States. If you have or are currently taking Actos, consult your physician about the possible increase in your risk for bladder cancer.

If you or a loved one has taken Actos and have suffered, contact Houston, Texas personal injury attorney Brian White & Associates today. We are standing by 24-7.  All consultations are free and there are no attorney’s fees unless we recover money for you.

This article is provided for informational purposes only. If you need legal advice or representation,
click here to have an attorney review your case .
NOLODRUPAL-web1:DRU1.6.12.2.20161011.41205